ArticleCancer science2022

Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.

Masaki Shiota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.